Bill Text: MD HB666 | 2017 | Regular Session | Introduced
Bill Title: Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee
Spectrum: Partisan Bill (Democrat 74-0)
Status: (Introduced - Dead) 2017-02-23 - Hearing 2/23 at 1:00 p.m. [HB666 Detail]
Download: Maryland-2017-HB666-Introduced.pdf
